Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).

GenCure announces breakthrough first run of 80-liter bioreactor

August 14, 2019 By Cade Hildreth (CEO)

Biomanufacturing CDMO among first to harvest adult stem cells at large scale

SAN ANTONIO, Texas – In a breakthrough for the regenerative medicine industry, GenCure announced today that its biomanufacturing services team has successfully completed production runs expanding and harvesting human mesenchymal stem cells (hMSCs) in an 80-liter bioreactor. GenCure, a subsidiary of BioBridge Global (BBG), announced a major expansion of its biomanufacturing facilities in February of this year. [Read more…]

What are Placental Stem Cells? | What are Placental Stem Cells Used For?

July 21, 2019 By Cade Hildreth (CEO)

What are placental stem cells and what are placental stem cells used for? As placental stem cells get explored for a variety of therapeutic applications, these questions become increasingly important. The opportunity to collect placental stem cells is also a once in a lifetime opportunity. [Read more…]

Mesoblast’s Mesenchymal Precursor Cell (MPC) Therapy Receives Orphan Drug Designation

June 24, 2019 By Cade Hildreth (CEO)

Mesoblast (ASX:MSB; Nasdaq: MESO) announced that the U.S. FDA granted the company’s product candidate, Revascor, Orphan Drug Designation for prevention of gastrointestinal bleeding in patients with left ventricular assist devices.

Revascor, Mesenchymal Precursor Cells

Revascor is Mesoblast’s investigational cell therapy composed of 150 million allogeneic mesenchymal precursor cells (MPCs). [Read more…]

Dr. Chris Centeno, Visionary Behind Regenexx® Stem Cell Technology

February 9, 2019 By Cade Hildreth (CEO)

Dr. Chris Centeno is an international expert in regenerative medicine and the clinical use of mesenchymal stem cells (MSCs) for orthopedic applications. This is Part 2 of an interview with Dr. Centeno.

Read Part 1 of the interview here.

ACL Surgeries and Regenexx Stem Cell Technology

Dr. Centeno specializes in clinical use of adult stem cells for orthopedic injuries, which he treats through same-day procedures at his clinic in Denver, Colorado, and through cultured expansion of mesenchymal stem cells at a clinic in Grand Cayman. He first performed these adult stem cell procedures in the U.S. in 2005-2006, and his clinic has since has treated thousands orthopedic patients with stem cell based therapies.

Dr. Chris Centeno is best known for the Regenexx® technology, an approach that uses needle-based procedures coupled with sophisticated guidance techniques to place large numbers of stem cells at the site needing repair. This approach can often replace the need for invasive orthopedic surgeries. [Read more…]

Regenexx – Dr. Chris Centeno on the Orthopedic Applications of MSCs

February 9, 2019 By Cade Hildreth (CEO)

Dr. Chris Centeno, CEO of Regenexx — Dr. Chris Centeno, Founder and CEO of Regenexx

Regenexx is a U.S. company specializing in orthopedic applications of stem cells that was founded by Dr. Chris Centeno. Dr. Centeno is an international expert in regenerative medicine and the clinical use of mesenchymal stem cells (MSCs) in orthopedic applications. His Regenexx clinic in Denver, Colorado, incorporates a variety of regenerative approaches, drawing patients from all over the U.S. who are seeking innovative, non-surgical treatments. [Read more…]